Arrowhead Pharmaceuticals, Inc. financial data

Symbol
ARWR on Nasdaq
Industry
Pharmaceutical Preparations
Location
177 E Colorado Blvd, Suite 700, Pasadena, California
State of incorporation
Delaware
Fiscal year end
September 30
Former names
ARROWHEAD RESEARCH CORP (to 4/6/2016), INTERACTIVE GROUP INC (to 1/9/2004), INTERACTIVE INC (to 2/13/2002)
Latest financial report
Q1 2024 - May 9, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 548 % +31.3%
Return On Equity -141 % -311%
Return On Assets -59.9 % -222%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 124 M shares +16.2%
Common Stock, Shares, Outstanding 124 M shares +16.2%
Entity Public Float 2.3 B USD -43.9%
Common Stock, Value, Issued 217 K USD +9.05%
Weighted Average Number of Shares Outstanding, Basic 123 M shares +15.5%
Weighted Average Number of Shares Outstanding, Diluted 123 M shares +14%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 35.5 M USD -87%
General and Administrative Expense 97 M USD -11.3%
Operating Income (Loss) -474 M USD -214%
Nonoperating Income (Expense) -4.29 M USD -280%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -478 M USD -222%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -471 M USD -213%
Earnings Per Share, Basic -4.25 USD/shares -199%
Earnings Per Share, Diluted -4.24 USD/shares -199%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 128 M USD -5.41%
Marketable Securities, Current 0 USD -100%
Accounts Receivable, after Allowance for Credit Loss, Current 0 USD -100%
Other Assets, Current 7.51 M USD -48%
Assets, Current 542 M USD -5.77%
Property, Plant and Equipment, Net 359 M USD +94%
Operating Lease, Right-of-Use Asset 44.6 M USD +8.54%
Other Assets, Noncurrent 210 K USD 0%
Assets 955 M USD +7.16%
Accounts Payable, Current 8.52 M USD -10.8%
Employee-related Liabilities, Current 13.7 M USD +150%
Accrued Liabilities, Current 37.1 M USD -6.31%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 65.2 M USD -25.2%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Operating Lease, Liability, Noncurrent 114 M USD +41.9%
Other Liabilities, Noncurrent 669 K USD
Accumulated Other Comprehensive Income (Loss), Net of Tax -1.1 M USD -230%
Retained Earnings (Accumulated Deficit) -1.28 B USD -57.9%
Stockholders' Equity Attributable to Parent 484 M USD +8.29%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 495 M USD +6.51%
Liabilities and Equity 955 M USD +7.16%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -118 M USD -56%
Net Cash Provided by (Used in) Financing Activities 267 K USD -99.9%
Net Cash Provided by (Used in) Investing Activities 64.8 M USD
Common Stock, Shares Authorized 290 M shares 0%
Common Stock, Shares, Issued 124 M shares +16.2%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 94.4 M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 128 M USD -5.38%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 285 M USD +17.4%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 304 M USD +15.8%
Operating Lease, Liability 119 M USD +43.7%
Payments to Acquire Property, Plant, and Equipment 68.7 M USD +76.4%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -154 M USD -22.6%
Lessee, Operating Lease, Liability, to be Paid 195 M USD +30.5%
Property, Plant and Equipment, Gross 409 M USD +84.9%
Operating Lease, Liability, Current 5.29 M USD +94.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 15.7 M USD +33%
Lessee, Operating Lease, Liability, to be Paid, Year One 15.4 M USD +89.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure -11.8%
Deferred Income Tax Expense (Benefit) 0 USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 75.9 M USD +14.2%
Lessee, Operating Lease, Liability, to be Paid, Year Three 14.9 M USD +22.5%
Deferred Tax Assets, Operating Loss Carryforwards 60.5 M USD -64.7%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) 0 USD
Current Income Tax Expense (Benefit) 2.78 M USD -26.4%
Preferred Stock, Shares Authorized 5 M shares 0%
Unrecognized Tax Benefits 14.5 M USD +318%
Lessee, Operating Lease, Liability, to be Paid, Year Four 13.5 M USD +19.6%
Operating Lease, Payments 2.05 M USD +86.3%
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 304 K USD +15100%
Current Federal Tax Expense (Benefit) 1.07 M USD
Amortization of Intangible Assets 1.7 M USD 0%
Depreciation, Depletion and Amortization 14.1 M USD +58.4%
Share-based Payment Arrangement, Expense 16.6 M USD -19.5%
Deferred State and Local Income Tax Expense (Benefit) 0 USD
Interest Expense 23 M USD +43.2%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%